AU5953090A - Novel use of 1-phenyl-2-aminoethanol derivatives as healing agents - Google Patents

Novel use of 1-phenyl-2-aminoethanol derivatives as healing agents

Info

Publication number
AU5953090A
AU5953090A AU59530/90A AU5953090A AU5953090A AU 5953090 A AU5953090 A AU 5953090A AU 59530/90 A AU59530/90 A AU 59530/90A AU 5953090 A AU5953090 A AU 5953090A AU 5953090 A AU5953090 A AU 5953090A
Authority
AU
Australia
Prior art keywords
phenyl
novel use
healing agents
aminoethanol derivatives
aminoethanol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU59530/90A
Inventor
Jean-Claude Plassard
Michel Vaugon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim France SAS
Original Assignee
Boehringer Ingelheim France SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim France SAS filed Critical Boehringer Ingelheim France SAS
Publication of AU5953090A publication Critical patent/AU5953090A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Birds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
AU59530/90A 1989-06-23 1990-06-20 Novel use of 1-phenyl-2-aminoethanol derivatives as healing agents Abandoned AU5953090A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8908374 1989-06-23
FR8908374A FR2648709A1 (en) 1989-06-23 1989-06-23 NOVEL USE OF 1-PHENYL-2-AMINOETHANOL DERIVATIVES AS HEALING MEANS

Publications (1)

Publication Number Publication Date
AU5953090A true AU5953090A (en) 1991-01-17

Family

ID=9383051

Family Applications (1)

Application Number Title Priority Date Filing Date
AU59530/90A Abandoned AU5953090A (en) 1989-06-23 1990-06-20 Novel use of 1-phenyl-2-aminoethanol derivatives as healing agents

Country Status (7)

Country Link
EP (1) EP0431154A1 (en)
JP (1) JPH04501568A (en)
KR (1) KR920700627A (en)
AU (1) AU5953090A (en)
CA (1) CA2035470A1 (en)
FR (1) FR2648709A1 (en)
WO (1) WO1991000088A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9321341D0 (en) * 1993-10-15 1993-12-08 Bristol Myers Squibb Co Therapeutic compositions for use in the treatment of skin lesions and method of making same
HUP0300832A2 (en) * 2000-04-27 2003-08-28 Boehringer Ingelheim Pharma Gmbh & Co. Kg Novel, slow-acting betamimetics, a method for their production and their use as medicaments and pharmaceutical compositions containing them
US8410102B2 (en) 2003-05-27 2013-04-02 Galderma Laboratories Inc. Methods and compositions for treating or preventing erythema
PL2182960T3 (en) * 2007-07-27 2014-08-29 Galderma Laboratories Inc Compounds, formulations, and methods for reducing skin wrinkles, creasing and sagging
EP2329849B1 (en) 2009-11-18 2015-04-29 Galderma Research & Development Combination of alpha-2 adrenergic receptor agonist and non-steroidal anti-inflammatory agent for treating or preventing an inflammatory skin disorder
US8394800B2 (en) * 2009-11-19 2013-03-12 Galderma Laboratories, L.P. Method for treating psoriasis
AU2011231543B2 (en) 2010-03-26 2015-01-15 Galderma Research & Development Improved methods and compositions for safe and effective treatment of erythema
BR112012024476A2 (en) 2010-03-26 2017-03-01 Galderma Res & Dev method for providing safe and effective treatment of telangiectasia and method of producing a packaged product
US8053427B1 (en) 2010-10-21 2011-11-08 Galderma R&D SNC Brimonidine gel composition
RU2571277C2 (en) 2010-10-21 2015-12-20 Галдерма С.А. Gel compositions with brimonidine and methods of application

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4285967A (en) * 1978-06-30 1981-08-25 Estee Lauder Inc. Cosmetic preparation for reducing redness of blemishes
DE3579343D1 (en) * 1984-03-07 1990-10-04 Roshdy Ismail AGENTS FOR TREATING AND PROTECTING THE SKIN.
US4552899A (en) * 1984-04-09 1985-11-12 Analgesic Associates Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs

Also Published As

Publication number Publication date
FR2648709A1 (en) 1990-12-28
CA2035470A1 (en) 1990-12-24
WO1991000088A1 (en) 1991-01-10
EP0431154A1 (en) 1991-06-12
KR920700627A (en) 1992-08-10
JPH04501568A (en) 1992-03-19

Similar Documents

Publication Publication Date Title
EP0432600A3 (en) Derivatives of 2-iminopyridine
AU1928388A (en) Surgical dressing
AU661018B2 (en) Further novel 5-amino-4-hydroxyhexanoic acid derivatives as therapeutic agents
AU6434390A (en) Treatment of ards
AU6806487A (en) Tissue plasminogen activator
AU6107390A (en) Use of amide complex compounds
AU622007B2 (en) Derivatives of thieno-triazolo-diazepine, a preparation process of the same and therapeutic compositions
AU5953090A (en) Novel use of 1-phenyl-2-aminoethanol derivatives as healing agents
AU613543B2 (en) Preparation of halofluorobenzenes
AU629002B2 (en) Preparation of tertiary-hydrocarbylsilyl compounds
AU5185790A (en) Treatment of tibial dyschondroplasia
AU5493190A (en) Thieno-triazolo-diazepine derivatives, a preparation process of the same and therapeutic compositions containing them
AU1767688A (en) Use of dioxopiperidine derivatives as analgesics
AU6660090A (en) Treatment of depression
AU6180486A (en) Novel tissue plasminogen activator derivatives
AU4552389A (en) Preparation of n-acyl-aminomethylphosphonates
AU6414190A (en) Treatment of carbohydrates
AU6527390A (en) Pharmaceutical compositions for the treatment of ataxy and equilibrium problems
AU6357890A (en) Expression of alpha-macroglobulins
YU53490A (en) Derivatives of tetrahydronaphtaline
AU6594690A (en) Therapeutic agents
AU1541088A (en) Composition for the treatment of the epiderm
AU4958690A (en) Preparation of 2-halofluorobenzene
AU5907190A (en) Preparation of polyacetals
AU624262B2 (en) Use of prophenytoin for treating stroke